Home › Endometrial Cancer › Alaska
Endometrial Cancer clinical trials in Alaska
5 studies for Endometrial Cancer are looking for participants at sites in Alaska.
Cities in Alaska
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Alaska Women's Cancer Care, Anchorage
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05256225Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Alaska Women's Cancer Care, Anchorage
RecruitingPhase 2
All ages · All sexes · Updated Sep 28, 2026 · NCT05564377Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Alaska Women's Cancer Care, Anchorage
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT07198074Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Alaska Womens Cancer Care, Anchorage
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 24, 2026 · NCT05640999A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Alaska Women's Cancer Care ( Site 6036), Anchorage
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06952504From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.